ResMed (RMD) Revenue & Quarterly History
Explore ResMed Inc. (RMD) revenue from 2023 through the latest reported quarter, with SEC-sourced comparisons and filing-constrained analysis.
Key takeaway
Quarter ended Mar 31, 2026 · FY2026 Q3
Revenue increased in the current quarter compared to the prior quarter. Revenue also rose compared to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.4B
Revenue reported for this quarter.
Quarter-over-quarter
+0.6%
Change from the immediately preceding quarter.
Year-over-year
+10.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$5.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2025 | $1.3B | +10.2% |
| Sep 30, 2025 | $1.3B | +9.1% |
| Dec 31, 2025 | $1.4B | +11.0% |
| Mar 31, 2026 | $1.4B | +10.8% |
Revenue performance
The reported revenue direction is positive, with a sequential increase from the immediately preceding quarter.
Quarterly comparison
Compared to the same quarter one year earlier, revenue was higher. The trailing twelve-month revenue also reflects sustained growth.
What to watch
Monitor whether the sequential revenue growth rate can be maintained in future quarters.